Get Started

ALNY

NASD Alnylam Pharmaceuticals, Inc
Nov 5, 2026 · 9:20 AM ET LAST TRADE Market Closed

$168.08 ↑ +7.00 (+4.35%) Trading Up from the previous close of $161.08

YTD change
-57.73%
vs 20-day SMA
-20.78%
vs 200-day SMA
-40.50%

Price ranges

Previous day
$160.29 $170.49
open $165.82 close $161.08
-$4.74 (-2.86%)
Today
$0.00 $0.00
$168.08
Past week
$156.00 $232.40
from $232.40 now $168.08
-$64.32 (-27.68%)
Past month
$156.00 $238.96
from $224.41 now $168.08
-$56.33 (-25.10%)
This year
$156.00 $427.05
from $397.65 now $168.08
-$229.57 (-57.73%)

Price & Performance

-140.03 (-46.50%) / 6M

$144.76$208.75$272.75$336.74May 5Aug 5Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 66.1% away from all-time highs of $495.55
  • ALNY is down 58% since the beginning of the year
  • ALNY is down 61% over the past 12 months
  • ALNY is down 25% over the past 1 month
  • 5% of all ALNY investors are betting against ALNY

ALNY reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -62.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $15.72
Earnings momentum -814.6% Quarterly EPS growth
Quarterly change -814.6%

Valuation

P/E ratio 8.07
Enterprise value $21.6B
Beta 1.04

Balance sheet & scale

Income$2.7M
Revenue$5.0B
Cash$3.6B
Debt$3.0M
Income / Debt 0.91×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $22.5B

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,417.99 +0.61%
JNJ Johnson & Johnson $276.32 +3.81%
ABBV AbbVie, Inc. $294.83 +3.09%
MRK Merck & Co., Inc. $150.36 +3.93%
RHHBY Roche Holding Ltd Sponsored ADR $60.94 +2.97%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.